This news is extremely important for the Vattikuti Foundation's colleagues performing Robotic Kidney Transplant With Regional Hypothermia. Research at the MedUni Vienna and University Hospital Vienna, Department of Medicine III, which was published December 20, 2021 in the journal JAMA Internal Medicine, reveals that even after three vaccinations, kidney transplant patients who take immunosuppressive drugs on a permanent basis fail to develop adequate protection against SARS-CoV-2. (These drugs are required to prevent organ rejection- and taken for the life of the patient.). While studies to develop a "cocktail' to fight the COVID-19 virus at MedUni Vienna continue, Kidney Transplant Recipients need to be made aware of the fact that they need to take extra precautions until a vaccine can be found for them.